PRESS RELEASE

from Ferratum Oyj (isin : FI4000106299)

Original-Research: Multitude SE (von NuWays AG): BUY

Original-Research: Multitude SE - from NuWays AG

Classification of NuWays AG to Multitude SE

Company Name: Multitude SE
ISIN: FI4000106299

Reason for the research: Update
Recommendation: BUY
from: 06.03.2024
Target price: 10.00
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Frederik Jarchow

Small value-accretive acquisition through CapitalBox; chg

Yesterday, Multitude announced to have acquired the Danish factoring specialist Omniveta Finance through its SME unit CapitalBox. Last week, CapitalBox also launched a new collateral lending product. In detail:

Value-accretive acquisition. Founded in 2012, Omniveta is a factoring specialist, that is purchasing invoices (eNuW: on avg. 30 days credit period) from suppliers with a certain discount (eNuW: 10-20%, including handling fees). With that, Omniveta is improving the overall liquidity of Danish SME´s. We expect that the company is generating a low single digit million Euro amount in sales and being more or less break-even on the bottom line. Multitude is seen to have paid You can download the research here:
http://www.more-ir.de/d/29079.pdf
For additional information visit our website www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++

-------------------transmitted by EQS Group AG.-------------------

The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

See all Ferratum Oyj news